Prognostic factors in sporadic colon cancer with high-level microsatellite instability

Surgery (United States)

Volumn 159, Issue 5, 2016, Pages 1372-1381

  Oh, Bo Young ^a   Huh, Jung Wook ^a   Park, Yoon Ah ^a   Cho, Yong Beom ^a   Yun, Seong Hyeon ^a   Kim, Hee Cheol ^a   Lee, Woo Yong ^a   Chun, Ho Kyung ^b  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURGERY; COLON CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; OVERALL SURVIVAL; PERINEURAL INVASION; PRIORITY JOURNAL; SURVIVAL RATE; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; CANCER STAGING; COLONIC NEOPLASMS; FOLLOW UP; GENETICS; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84953449496     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2015.11.028     Document Type: Article

References (28)

1. S. Ziadi, F. Ksiaa, R. Ben Gacem, N. Labaied, M. Mokni, and M. Trimeche Clinicopathologic characteristics of colorectal cancer with microsatellite instability Pathol Res Pract 210 2014 98 104
2. J.H. Kim, J.M. Bae, K.J. Kim, Y.Y. Rhee, Y. Kim, N.Y. Cho, and et al. Differential features of microsatellite-unstable colorectal carcinomas depending on EPCAM expression status Korean J Pathol 48 2014 276 282
3. J. Goldstein, B. Tran, J. Ensor, P. Gibbs, H.L. Wong, S.F. Wong, and et al. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H) Ann Oncol 25 2014 1032 1038
4. F.A. Sinicrope, N.R. Foster, S.N. Thibodeau, S. Marsoni, G. Monges, R. Labianca, and et al. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy J Natl Cancer Inst 103 2011 863 875
5. S.Y. Oh, Y. Kim do, Y.B. Kim, and K.W. Suh Oncologic outcomes after adjuvant chemotherapy using FOLFOX in MSI-H sporadic stage III colon cancer World J Surg 37 2013 2497 2503
6. Z. Saridaki, J. Souglakos, and V. Georgoulias Prognostic and predictive significance of MSI in stages II/III colon cancer World J Gastroenterol 20 2014 6809 6814
7. N. Devaud, and S. Gallinger Chemotherapy of MMR-deficient colorectal cancer Fam Cancer 12 2013 301 306
8. S.J. Kim, H.R. Kim, S.H. Kim, J.H. Han, Y.B. Cho, S.H. Yun, and et al. hMLH1 promoter methylation and BRAF mutations in high-frequency microsatellite instability colorectal cancers not fulfilling the revised Bethesda guidelines Ann Surg Treat Res 87 2014 123 130
9. C.R. Boland, S.N. Thibodeau, S.R. Hamilton, D. Sidransky, J.R. Eshleman, R.W. Burt, and et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 58 1998 5248 5257
10. N. Suraweera, A. Duval, M. Reperant, C. Vaury, D. Furlan, K. Leroy, and et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR Gastroenterology 123 2002 1804 1811
11. G. Berginc, and D. Glavac Rapid and accurate approach for screening of microsatellite unstable tumours using quasimonomorphic mononucleotide repeats and denaturating high performance liquid chromatography (DHPLC) Dis Markers 26 2009 19 26
12. R. Gryfe, H. Kim, E.T. Hsieh, M.D. Aronson, E.J. Holowaty, S.B. Bull, and et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer N Engl J Med 342 2000 69 77
13. C.M. Ribic, D.J. Sargent, M.J. Moore, S.N. Thibodeau, A.J. French, R.M. Goldberg, and et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 2003 247 257
14. S. Popat, R. Hubner, and R.S. Houlston Systematic review of microsatellite instability and colorectal cancer prognosis J Clin Oncol 23 2005 609 618
15. M.M. Bertagnolli, M. Redston, C.C. Compton, D. Niedzwiecki, R.J. Mayer, R.M. Goldberg, and et al. Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer-a study of CALGB 9581 and 89803 J Clin Oncol 29 2011 3153 3162
16. S.N. Thibodeau, G. Bren, and D. Schaid Microsatellite instability in cancer of the proximal colon Science 260 1993 816 819
17. T. Ishikubo, Y. Nishimura, K. Yamaguchi, U. Khansuwan, Y. Arai, T. Kobayashi, and et al. The clinical features of rectal cancers with high-frequency microsatellite instability (MSI-H) in Japanese males Cancer Lett 216 2004 55 62
18. O. Nehls, H.G. Hass, T. Okech, S. Zenner, C.J. Hsieh, M. Sarbia, and et al. Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery alone Int J Colorectal Dis 24 2009 655 663
19. H. Elsaleh, B. Powell, P. Soontrapornchai, D. Joseph, F. Goria, N. Spry, and et al. p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma Oncology 58 2000 52 59
20. E. Nardon, D. Glavac, J. Benhattar, P.J. Groenen, G. Hofler, H. Hofler, and et al. A multicenter study to validate the reproducibility of MSI testing with a panel of 5 quasimonomorphic mononucleotide repeats Diagn Mol Pathol 19 2010 236 242
21. D.J. Sargent, S. Marsoni, G. Monges, S.N. Thibodeau, R. Labianca, S.R. Hamilton, and et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer J Clin Oncol 28 2010 3219 3226
22. M.M. Bertagnolli, D. Niedzwiecki, C.C. Compton, H.P. Hahn, M. Hall, B. Damas, and et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803 J Clin Oncol 27 2009 1814 1821
23. S.T. Kim, J. Lee, S.H. Park, J.O. Park, H.Y. Lim, W.K. Kang, and et al. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy Cancer Chemother Pharmacol 66 2010 659 667
24. C.I. Muller, K. Schulmann, A. Reinacher-Schick, N. Andre, D. Arnold, A. Tannapfel, and et al. Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group Int J Colorectal Dis 23 2008 1033 1039
25. G. des Guetz, P. Mariani, J. Cucherousset, M. Benamoun, C. Lagorce, X. Sastre, and et al. Microsatellite instability and sensitivity to FOLFOX treatment in metastatic colorectal cancer Anticancer Res 27 2007 2715 2719
26. G. Des Guetz, B. Uzzan, P. Nicolas, O. Schischmanoff, G.Y. Perret, and J.F. Morere Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis Anticancer Res 29 2009 1615 1620
27. J.T. Liang, K.C. Huang, H.S. Lai, P.H. Lee, Y.M. Cheng, H.C. Hsu, and et al. High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection Int J Cancer 101 2002 519 525
28. W.M. Brueckl, C. Moesch, T. Brabletz, C. Koebnick, C. Riedel, A. Jung, and et al. Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy Anticancer Res 23 2003 1773 1777